Results 181 to 190 of about 656,131 (350)
Type 2 diabetes mellitus in patients with ischemic stroke – A nationwide study [PDF]
Sidsel Hastrup +4 more
openalex +1 more source
Cerebral ischemia‐reperfusion injury (CIRI) is a key pathological process limiting the efficacy of stroke therapy. This study has developed an innovative, multifunctional, brain‐targeted nanoplatform (RFP) containing MXene nanoenzymes and ferroptosis inhibitors.
Lu Wang +9 more
wiley +1 more source
The Cerebellar Connectome Disruptions in Ischemic Stroke. [PDF]
Wang X +9 more
europepmc +1 more source
Disrupting CSPG‐Driven Microglia–Astrocyte Crosstalk Enables Scar‐Free Repair in Spinal Cord Injury
This study identifies CSPGs as key drivers of glial scar maturation after spinal cord injury by reprogramming microglial metabolism and inducing astrocyte fibrosis. To address this, a reactive oxygen species‐responsive, reactive astrocyte‐targeted ChABC gene delivery system is designed to locally degrade CSPGs, precisely disrupt maladaptive glial ...
Yufei Zheng +10 more
wiley +1 more source
Monocyte-derived macrophages and their roles in ischemic stroke. [PDF]
Dufort C +9 more
europepmc +1 more source
Correlation Between Neuron-Specific Enolase and Serum Glucose Level in Patients with Acute Ischemic Stroke [PDF]
Hong Duc Thi Nguyen
openalex +1 more source
This study identifies CRISPLD2 as a key protector against IVDD. By regulating ferroptosis through the CRISPLD2–miR‐548I–IL17A axis, CRISPLD2 maintains NPCs homeostasis and reduces oxidative stress. Restoring CRISPLD2 expression effectively alleviates disc degeneration and highlights a promising therapeutic strategy for discogenic low back pain ...
Yangyang Shi +11 more
wiley +1 more source
Interleukin‑6 and ischemic stroke: From mechanisms to clinical prospects (Review). [PDF]
Wang X, Zhang X, Lin J, Lin P.
europepmc +1 more source
Diagnostic Work-Up and Etiology in Ischemic Stroke in Young Adults: Before and Now
José F. Varona
openalex +1 more source
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley +1 more source

